Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy.

AIDS (London, England) - 8 Mar 2002

Cohen Calvin J, Hunt Susan, Sension Michael, Farthing Charles, Conant Marcus, Jacobson Susan, Nadler Jeffrey, Verbiest Werner, Hertogs Kurt, Ames Michael, Rinehart Alex R, Graham Neil M

Abstract excerpt

OBJECTIVE: To compare the effect of treatment decisions guided by phenotypic resistance testing (PRT) or standard of care (SOC) on short-term virological response. DESIGN: A prospective, randomized, controlled clinical trial conducted in 25 university and private practice centers in the United States. PARTICIPANTS: A total of 272 subjects who failed to achieve or maintain virological suppression (HIV-1-RNA plasma...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to CD4 Lymphocyte Count

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to HIV Protease Inhibitors

Share to Practice Guidelines as Topic

Share to Reverse Transcriptase Inhibitors

Share to United States

Share to Viral Load

Source

Identifiers

PMID: 11873001
DOI: 10.1097/00002030-200203080-00009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy.PMID 11873001Read ↗

Antiretroviral drug resistance testing in patients with HIV-1 infection: a meta-analysis study.Semantic proximity Read ↗

Limited benefit of antiretroviral resistance testing in treatment-experienced patients: a meta-analysis.Semantic proximity Read ↗

A randomized, prospective study of phenotype susceptibility testing versus standard of care to manage antiretroviral therapy: CCTG 575.Semantic proximity Read ↗

A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS.Semantic proximity Read ↗

Comparison of HIV-1 genotypic resistance test interpretation systems in predicting virological outcomes over time.Semantic proximity Read ↗

Net benefits of resistance testing directed therapy compared with standard of care in HIV-infected patients with virological failure: A meta-analysis.Semantic proximity Read ↗

A randomized controlled trial of the value of phenotypic testing in addition to genotypic testing for HIV drug resistance: evaluation of resistance assays (ERA) trial investigators.Semantic proximity Read ↗

Selection of antiretroviral therapy guided by genotypic or phenotypic resistance testing: an open-label, randomized, multicenter study (PhenGen).Semantic proximity Read ↗

Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial.Semantic proximity Read ↗

Impact of genotypic resistance testing on physician selection of antiretroviral therapy.Semantic proximity Read ↗

Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA).Semantic proximity Read ↗

How testing for HIV resistance influences therapeutic decision making. Analysis of a sample of 600 clinicians.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.